We offer to make joint ventures on existing production areas of BZMP JSC:

1. Joint venture for production of drugs in the form of solutions for injections in ampoules:

a) by whole reconstruction of the injection production workshop:

Statutory fund – 63.3 million US dollars Shares of participants: JSC “BZMP” – 23.3 million US dollars – 36.8% Investor – 40.0 million US dollars – 63.2%

b) by partially reconstruction of the injection production workshop:

Statutory fund – 43,3 million US dollars

Shares of participants:

JSC “BZMP” – 23.3 million US dollars – 53,8%

Investor – 20.0 million US dollars – 46,2%

JSC “BZMP”:

a)hands over its existing production sites and equipment for production of solutions for injections in ampoules;

b)hands over the range of products in the form of solutions for injections.

Investor:

a) pays the cost of the reconstruction of ampoule production;

b) offers a new range of medical products.

2. Joint venture for production of medical products in the form of tablets

Collective investment fund – 22,5 million US dollars

Shares of participants :

JSC “BZMP” – 7.5 mln. USD – 33.3%

Investor – 15.0 mln. USD – 66.7%

JSC “BZMP”:

a) hands over a part of its existing production sites and equipment for production of medical products in the form of tablets;

b)hands over a part of the range of products in the form of tablets.

Investor:

a) pays the cost of the reconstruction of existing tablet production;

b) offers a new range of medical products.

Contacts: Deputy of general director in economics – LARISA SATSUK

Tel.: (+375 177) 75 49 37

Fax:(+375 177) 73 24 25

e-mail: salar@borimed.com

We invite you for cooperatio